Normal Healthy Subjects Clinical Trial
Official title:
A Clinical Trial of Silk Peptide for the Evaluation of Efficacy on Immune Function Enhancement
This study is a 8-week, randomized, double-blind, placebo-controlled clinical trial of Silk Peptide for the evaluation of efficacy on immune function enhancement.
This study will evaluate Silk Peptide's efficacy on immune function in healthy volunteers who white blood cells count is in between 4000/㎕ and 8000/㎕ by assessing improvements in certain immune indices (i.e. NK cell activity, IFN-γ, TNF-α, IL-1β, 2, 12, IgG1, IgG2). ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01941446 -
A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization
|
Phase 1 | |
| Completed |
NCT05447546 -
Study to Evaluate HT-6184 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01652859 -
An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03677921 -
A Clinical Trial of Bio-Germanium for the Evaluation of Efficacy on Immune Function
|
N/A |